Eli Lilly’s New Obesity Drug Shows 11% Weight Loss
Reading Time: 3 minutesEloralintide, Eli Lilly’s new obesity drug, helped patients lose 11.5% body weight in 12 weeks. Learn how it compares with GLP-1s like Zepbound.
Eli Lilly’s New Obesity Drug Shows 11% Weight Loss Read More »
Blogs, Pharmacology





